Intraarticular Tranexamic Acid Decreased Transfusion Rates and Blood Loss in Primary Total Hip Arthroplasty: A Prospective Randomized Double-Blind Placebo-Controlled Trial

Article Sidebar

pdf
Published: Apr 29, 2016
Keywords:
Tranexamic acid Intraarticular Total hip arthroplasty Transfusion rate Blood loss

Main Article Content

Jithayut Sueajui
Department of Orthopedics Surgery, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand
Nuttawut Chanalithichai
Department of Orthopedics Surgery, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand
Urawit Piyapromdee
Department of Orthopedics Surgery, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand
Yingyong Suksathien
Department of Orthopedics Surgery, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand

Abstract

Backgrounds: Total hip arthroplasty (THA) often requires blood transfusion postoperatively. Tranexamic acid (TXA) has been successfully used intravenously to control bleeding. Intraarticular TXA is safe and effective at reducing postoperative bleeding in orthopedic procedures, but there is limited literature regarding its use in THA. The objective of this prospective randomized study was to determine if intraarticular TXA decreased postoperative transfusion rates and bleeding after primary THA.


Propose: To study the efficacy of intraarticular tranexamic acid to decrease postoperative transfusion rates and blood loss after primary total hip arthroplasty.


Methods: A prospective double-blinded, randomized controlled trial of 135 primary THA of 118 patients investigated the efficacy of intraarticular application of TXA on blood loss compared with a placebo in Maharat Nakhon Ratchasima Hospital during the period from September 2013 to March 2015. Intraarticular TXA (750 mg) was applied after acetabular and femoral canal preparation. The primary outcome was blood transfusion rate, the mean drain blood loss, and total blood loss by Gross formula. Secondary outcomes include the units of blood transfusion, nadir post-operative hemoglobin and hematocrit, hemoglobin and hematocrit concentration change, visual analog scales (VAS), length of hospital stay, and up to 12 weeks follow-up for surveillance complications.


Results: Patients in the TXA group insignificantly improved in reduction of transfusion rates (TXA group = 39.7%, Placebo = 55.2%; P-value = 0.07), drain blood loss (TXA group = 535 mL, Placebo = 540mL; P-value = 0.45), and total blood loss by Gross formula (TXA group = 771 mL, Placebo = 757 mL; P-value = 0.59) compared with the placebo. However, the units of blood transfused decreased significantly in the TXA group cases compared to the placebo (TXA = 0.53 units per case, Placebo = 0.88 units per case; P-value=0.035). Visual analog scales (VAS) also reduced significantly in the TXA group (TXA = 3.9, Placebo = 4.7; P-value=0.001). There were three complications in the tranexamic acid group (two acute febrile illness and one dislocation) and five in the placebo group (one superficial infection, two acute febrile illness and two dislocation). There was no sciatic nerve irritation from the diluted dose of tranexamic acid used in the study.


Conclusions: The use of 750mg intraarticular tranexamic acid in patients undergoing THA does not effectively reduce postoperative blood transfusion rates and bleeding. However, the units of transfusion (units per case) and visual analog scale could be declined statistically significantly.

Article Details

Issue
Vol. 40 No. 1-2 (2016): January-April
Section
Original Articles

References

1. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81(1):2.
2. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008;90-B:1128.
3. Cardone D, Klein AA. Perioperative blood conservation. Eur J Anaesthesiol 2009;26:722.
4. Rajesparan K, Biant LC, Ahmad M, et al. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009;91:776.
5. Ralley FE, Berta D, Binns V, Field RE. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010;468:1905.
6. Sano M, Hakusui H, Kojima C, Akimoto T. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administration in healthy volunteers. Clin Pharmacol Ther 1976;7:375.
7. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty.J Bone Joint Surg Am 2005;87:766.
8. Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010;104:23.
9. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Semin Thromb Hemost 1997;23:493.
10. Prentice CR. Basis of antifibrinolytic therapy. J Clin Pathol, Suppl (R Coll Pathol) 1980;14:35.
11. Eubanks JD. Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 2010;18(3):132.
12. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011;3:CD001886.
13. Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012;94(13):1153.
14. Mannucci PM. Hemostatic Drugs. N Engl J Med 1998;339(4):245.
15. Raveendran R, Wong J. Tranexamic acid reduces blood transfusion in surgical patients while its effects on thromboembolic events and mortality are uncertain. Evid Based Med 2013;18(2):65
16. Krohn CD, Sorensen R, Lange JE, Riise R, Bjørnsen S, Brosstad F. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. Eur J Surg Suppl 2003;588:57.
17. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010;92(15):2503.
18. Gandhi R, Evans HMK, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013;6:184.
19. Kim TK, Chang CB, Koh IJ. Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surgery, Sports Traumatology, Arthroscopy 2014; 22(8): 1849-1858.
20. Wind TC, Barfield WR, Moskal JT. The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty. 2013 Aug;28(7):1080-3.
21. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical Administration of Tranexamic Acid in Primary Total Hip and Total Knee Arthroplasty, J Arthroplasty. 2014 May;29(5):889-94.
22. Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. : Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Knee Replacement A Randomized Controlled Trial (TRANX-K) , J Bone Joint Surg Am. 2013;95:1961-8
23. Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates Associated With Primary Total Hip Arthroplasty, Clin Orthop Relat Res. 2014 May;472(5):1552-7.
24. Konig G, Hamlin BR, Waters JH. Topical Tranexamic Acid Reduces Blood Loss and Transfusion Rates in Total Hip and Total Knee Arthroplasty, J Arthroplasty. 2013 Oct;28(9):1473-6.
25. Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Hip Replacement ,A Randomized Controlled Trial (TRANX-H), J Bone Joint Surg Am. 2013;95:1969-74
26. Gilbody J, Dhotar HS, Perruccio AV, Davey JD. Topical Tranexamic Acid Reduces Transfusion Rates in Total Hip and Knee Arthroplasty, J Arthroplasty. 2014 Apr;29(4):681-4.
27. Eipe NP, Ponniah M. Perioperative blood loss assessment- how accurate? Indian J Anaesth. 2006;50(1):35-8.
28. Duke J. Anesthesia secrets. Third ed. Philadelphia: Mosby Elsevier; 2006.
29. Carson JL, Terrin ML, Jay M. Anemia and postoperative rehabilitation. Can J Anaesth. 2003;50:S60–64.
30. Kuriyan M, Carson JL. Anemia and clinical outcomes. Anesthesiol. Clin North Am. 2005;23:315–325, vii.
31. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion. 1992;32:517–524.
32. Diamond PT, Conaway MR, Mody SH, Bhirangi K. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee arthroplasty. J Arthroplasty. 2006;21:636–641.
33. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113:3406–3417.
34. Lemos MJ, Healy WL. Blood transfusion in orthopaedic operations. J Bone Joint Surg Am. 1996;78:1260–1270.
35. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011 Jan; 93(1):39-46.
36. Gross JB. Estimating Allowable Blood Loss: Corrected for Dilution. Anesthesiology 1983; 58(3): 277-80.